The South African Menopause Landscape Is Different

menopause treatment South Africa operates in a two-tier system that shapes everything about access and affordability. The private healthcare sector — covered by medical aid schemes like Discovery Health, Momentum, and Bonitas — offers access to specialist menopause care, body-identical HRT, and advanced diagnostics. The public sector, serving roughly 80 percent of the population through state hospitals, provides basic menopause care with limited HRT options.

The South African Menopause Society (SAMS) publishes clinical guidelines that align with international standards from NAMS and the International Menopause Society. SAMS released a revised consensus position statement on menopausal hormone therapy in 2014, and a statement on compounded bioidentical hormones in 2023. These documents form the clinical backbone for South African practitioners.

The country has a growing network of dedicated menopause clinics and online hormone services. Hormones with Heart, launched in 2024, is South Africa’s first doctor-led online hormone clinic, offering virtual consultations, body-identical HRT prescribing, and ongoing management. Larger private hospitals in Johannesburg, Cape Town, and Durban have gynaecologists with menopause specialisation, but rural access remains limited.

HRT Availability: What You Can Get and What You Cannot

South Africa has access to most standard hrt formulations, though availability varies by region and pharmacy stock levels.

Transdermal estradiol patches (Estradot, Estramon) are available and covered by most medical aids on the Chronic Disease List. A month’s supply of Estradot 50 mcg costs approximately R250 to R400 at private pharmacy prices, or R70 to R120 with medical aid co-payment. The 25 mcg and 100 mcg strengths are also available.

Oral estradiol (Zumenon, Estrofem) is available but less commonly prescribed in South Africa due to concerns about first-pass metabolism and the availability of transdermal alternatives. A month’s supply costs R150 to R300.

Vaginal estrogen is available as estriol cream (Ovestin, approximately R200 to R350 per tube lasting 8 to 12 weeks) and estradiol vaginal tablets (Vagifem, approximately R350 to R500 for 24 tablets). Both require a prescription and are covered by most medical aids.

Progesterone is available as micronized progesterone capsules (Utrogestan, 100 mg and 200 mg) at approximately R250 to R450 per month. Synthetic progestins like medroxyprogesterone acetate (Provera) are cheaper at R80 to R150 but are associated with worse mood and lipid profiles.

What is harder to find: testosterone for women. Testosterone is not registered for use in women in South Africa. Some compounding pharmacies prepare low-dose testosterone formulations, but these are unregulated and not covered by medical aid. The SAMS 2023 statement on compounded hormones explicitly warns against routine use of compounded bioidentical hormones when FDA-approved alternatives exist.

Veozah (fezolinetant) was not yet available in South Africa as of early 2026. It has not been registered with the South African Health Products Regulatory Authority (SAHPRA). The same applies to elinzanetant, the newer NK3 antagonist from the OASIS trials.

Costs in the Private Sector

The cost of menopause treatment in South Africa depends on whether you have medical aid and what level of cover you have.

A consultation with a private gynaecologist for menopause management ranges from R800 to R1,800. Specialized menopause clinics charge R1,200 to R2,500 for an initial consultation. Online services like Hormones with Heart charge approximately R950 for an initial virtual consultation.

Blood tests — estradiol, FSH, TSH, vitamin D, and lipid profile — cost R1,500 to R3,000 in private pathology labs (Lancet, Ampath, PathCare). Medical aid covers these if the correct ICD-10 code is submitted.

Monthly HRT costs range from R150 to R1,500 depending on the formulation:

Oral estradiol: R150 to R300 per month
Transdermal patches: R250 to R400 per month
Micronized progesterone: R250 to R450 per month
Vaginal estrogen: R200 to R500 per product (lasts 1 to 3 months)
Compounded testosterone (out of pocket): R400 to R800 per month

Medical aid schemes classify HRT under the Chronic Drug List for some plans. Discovery Health Medical Scheme’s 2024 DHMS Menopause Medicine List includes estradiol patches, oral estradiol, and micronized progesterone on the formulary, meaning members pay the chronic co-payment rate rather than full retail. Bonitas and Momentum have similar formularies.

Public Sector Treatment Options

Women relying on the public healthcare system face significant barriers to optimal menopause treatment.

State hospitals and clinics offer basic HRT — typically oral conjugated equine estrogen (Premarin) and medroxyprogesterone acetate (Provera) — at minimal or no cost. These are the same formulations used in the WHI trial, which means they carry the same risks that led to the 2002 scare. Transdermal patches are generally not available in the public sector.

The public sector guidelines, published by SASOG (South African Society of Obstetricians and Gynaecologists), recommend HRT for symptomatic women with no contraindications, but implementation is inconsistent. A 2024 survey of public sector doctors in Gauteng and Western Cape found that only 34 percent felt confident prescribing HRT, and fewer than 20 percent had received any menopause-specific training.

Non-hormonal options in the public sector are limited to over-the-counter supplements and basic antidepressants. SSRIs like escitalopram and citalopram are available on the Essential Medicines List and cost R30 to R80 per month at state pharmacy rates. Gabapentin is available but restricted to neuropathic pain indications.

Telemedicine and Online Options Are Growing

South Africa’s telemedicine landscape for menopause has expanded significantly since 2022. The Health Professions Council of South Africa (HPCSA) permits virtual consultations for follow-up care, and several platforms now offer initial online menopause assessments.

Hormones with Heart, launched in 2024, connects patients with a network of menopause-trained doctors for virtual consultations. The model is similar to Midi Health in the United States: a detailed intake questionnaire, a video consultation with a prescriber, and ongoing management with prescription delivery through a partner pharmacy.

The same platform serves as a hub for patient education, community support, and specialist referrals. For women in smaller towns or rural areas where menopause-specialist gynaecologists are hours away, this model fills a genuine gap.

The limitations: online clinics cannot provide pelvic exams or blood pressure monitoring. Women with complex medical histories — hypertension, breast cancer, clotting disorders — still need in-person care. Online HRT prescribing is best suited to otherwise healthy women with straightforward symptom management needs.

Supplements and Alternatives: What the Evidence Says

South African pharmacies stock an extensive range of menopause supplements — isoflavones, black cohosh, red clover, sage, and vitamin E. The evidence for most of these is weak to nonexistent.

The SASOG clinical guideline is direct on this point: “Herbal and complementary therapies for menopausal symptoms have limited evidence. Their use is not recommended as first-line therapy.” A 2025 review in the South African Medical Journal examined 14 commonly sold menopause supplements and found that only two — isoflavone extracts at doses above 50 mg daily and sage leaf preparations — had any evidence of efficacy, and even those were modest (20 to 30 percent symptom reduction).

Women in South Africa looking for effective menopause treatment should start with the options that have the strongest evidence: transdermal estradiol patches or gel, micronized progesterone, vaginal estrogen for local symptoms, and SSRIs or gabapentin for women who cannot use hormones. These are all available in South Africa, covered by most medical aids, and supported by decades of clinical research that applies to South African women as much as it does to women anywhere.